Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs cimetidine for prevention of rebleeding after endoscopic hemostasis in peptic ulcer bleeding
CTR20132682Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in Peptic ulcer disease (PUD), sponsored by AstraZeneca. Started Jun 2014; status: completed.
02
Drugs
esomeprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20132682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132682.